Jonathan Bye
Lawyers
Filters
RAPT Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…
Davis Polk Advises Pivotal Software on Its Sale to VMware
Davis Polk is advising Pivotal Software, Inc. in connection with its sale to VMware, Inc. for a total enterprise value of approximately $2.7 billion. Closing of the transaction is subject…
IDEAYA Biosciences, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 5,750,000 shares of common stock of IDEAYA Biosciences, Inc. at $10.00 per share (which includes the…
Weyerhaeuser Company $750 Million Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Weyerhaeuser Company of $750 million aggregate principal amount of its 4.00% senior notes due 2029…